International Journal of Hypertension [14] S. L. Wu, Z. Q. Zhang, S. B. Song et al., “Prevalence of prehypertension and associated cardiovascular risk: two years follow up results,” Chinese Journal of Epidemiology, vol. 38, no. 5, pp. 415–419, 2010. [15] S. A. Isezuo, A. A. Sabir, A. E. Ohwovorilole, and O. A. Fasanmade, “Prevalence, associated factors and relationship between prehypertension and hypertension: a study of two ethnic African populations in Northern Nigeria,” Journal of Human Hypertension, vol. 25, pp. 224–230, 2011. [16] A. Cordero, M. Laclaustra, M. Leo´ n et al., “Prehypertension is associated with insulin resistance state and not with an initial renal function impairment: a Metabolic Syndrome in Active Subjects in Spain (MESYAS) Registry substudy,” American Journal of Hypertension, vol. 19, no. 2, pp. 189–196, 2006. [17] Y. Zhang, E. T. Lee, R. B. Devereux et al., “Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the strong heart study,” Hypertension, vol. 47, no. 3, pp. 410–414, 2006. [18] B. J. Kim, H. J. Lee, K. C. Sung et al., “Comparison of microal- buminuria in 2 blood pressure categories of prehypertensive subjects,” Circulation Journal, vol. 71, no. 8, pp. 1283–1287, 2007. [19] C. Chrysohoou, C. Pitsavos, D. B. Panagiotakos, J. Skoumas, and C. Stefanadis, “Association between prehypertension status and inﬂammatory markers related to atherosclerotic disease: the ATTICA Study,” American Journal of Hypertension, vol. 17, no. 7, pp. 568–573, 2004. [20] T. Ninomiya, M. Kubo, Y. Doi et al., “Prehypertension increases the risk for renal arteriosclerosis in autopsies: the Hisayama study,” Journal of the American Society of Nephrol- ogy, vol. 18, no. 7, pp. 2135–2142, 2007. [21] B. Marilyn, W. Lawrence, B. Richard et al., “Association of prehypertension by joint national committee 7 criteria with left ventrieulur structure and function: the strong heart study,” Journal of the American College of Cardiology, vol. 17, no. 3, pp. 1142–1183, 2004. [22] A. V. Kshirsagar, M. Carpenter, H. Bang, S. B. Wyatt, and R. E. Colindres, “Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease,” American Journal of Medicine, vol. 119, no. 2, pp. 133–141, 2006. [23] A. I. Qureshi, M. F. Suri, J. F. Kirmani, A. A. Divani, and Y. Mohammad, “Is prehypertension a risk factor for cardiovascular diseases?” Stroke, vol. 36, no. 9, pp. 1859–1863, 2005. [24] S. Lewington, R. Clarke, N. Qizilbash, R. Peto, and R. Collins, “Age-speciﬁc relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies,” The Lancet, vol. 360, no. 9349, pp. 1903–1913, 2002. [25] R. S. Vasan, M. G. Larson, E. P. Leip, W. B. Kannel, and D. Levy, “Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study,” The Lancet, vol. 358, no. 9294, pp. 1682–1686, 2001. [26] T. Dorjgochoo, X. O. Shu, X. Zhang et al., “Relation of blood pressure components and categories and all-cause, stroke and coronary heart disease mortality in urban Chinese women: a population-based prospective study,” Journal of Hypertension, vol. 27, no. 3, pp. 468–475, 2009. [27] G. Mancia, G. De Backer, A. Dominiczak et al., “2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of 5 arterial hypertension,” Journal of Hypertension, vol. 25, no. 9, pp. 1751–1762, 2007. [28] N. M. Karanja, E. Obarzanek, P. H. Lin et al., “Descriptive characteristics of the dietary patterns used in the Dietary Approaches to Stop Hypertension trial,” Journal of the Amer- ican Dietetic Association, vol. 99, supplement 8, pp. S19–S27, 1999. [29] F. M. Sacks, L. P. Svetkey, W. M. Vollmer et al., “Eﬀects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (dash) diet,” New England Journal of Medicine, vol. 344, no. 1, pp. 3–10, 2001. [30] J. E. Neter, B. E. Stam, F. J. Kok, D. E. Grobbee, and J. M. Geleijnse, “Inﬂuence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials,” Hypertension, vol. 42, no. 5, pp. 878–884, 2003. [31] G. Cocco and S. Pandolﬁ, “Physical exercise with weight reduction lowers blood pressure and improves abnormal left ventricular relaxation in pharmacologically treated hyperten- sive patients,” Journal of Clinical Hypertension, vol. 13, no. 1, pp. 23–29, 2011. [32] F. P. Costa and S. H. Machado, “Does the consumption of salt and food rich in sodium inﬂuence in the blood pressure of the infants?” Ciencia e Saude Coletiva, vol. 15, supplement 1, pp. 1383–1389, 2010. [33] K. Miura, N. Okuda, T. C. Turin et al., “Dietary salt intake and blood pressure in a representative Japanese population: base- line analyses of NIPPON DATA80,” Journal of Epidemiology, vol. 20, supplement 3, pp. S524–S530, 2010. [34] N. R. Cook, J. A. Cutler, E. Obarzanek et al., “Long term eﬀects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hyperten- sion prevention (TOHP),” British Medical Journal, vol. 334, no. 7599, pp. 885–888, 2007. [35] G. A. Kelley and K. S. Kelley, “Progressive resistance exercise and resting blood pressure: a meta- analysis of randomized controlled trials,” Hypertension, vol. 35, no. 3, pp. 838–843, 2000. [36] S. P. Whelton, A. Chin, X. Xin, and J. He, “Eﬀect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials,” Annals of Internal Medicine, vol. 136, no. 7, pp. 493–503, 2002. [37] I. B. Puddey and L. J. Beilin, “Alcohol is bad for blood pres- sure,” Clinical and Experimental Pharmacology and Physiology, vol. 33, no. 9, pp. 847–852, 2006. [38] P. J. Elmer, E. Obarzanek, W. M. Vollmer et al., “Eﬀects of comprehensive lifestyle modiﬁcation on diet, weight, physical ﬁtness, and blood pressure control: 18-Month results of a randomized trial,” Annals of Internal Medicine, vol. 144, no. 7, pp. 485–495, 2006. [39] J. F. Martin, L. N. Martin, and J. P. Cipullo, “Pharmacologic treatment for prehypertension: to treat or not to treat?” Recent Patents on Cardiovascular Drug Discovery, vol. 4, no. 2, pp. 133–141, 2009. [40] S. Julius, S. D. Nesbitt, B. M. Egan et al., “Feasibility of treating prehypertension with an angiotensin-receptor blocker,” New England Journal of Medicine, vol. 354, no. 16, pp. 1685–1697, 2006. [41] J. A. Cade´e, C. Y. Chang, C. W. Chen, C. N. Huang, S. L. Chen, and C. K. Wang, “Bovine casein hydrolysate (C12 Peptide) reduces blood pressure in prehypertensive subjects,” American Journal of Hypertension, vol. 20, no. 1, pp. 1–5, 2007.